Heavy Buying Stock Under Rs 25: Debt-Free Microcap Company Bags Order Worth USD 1,01,680; Stock Gains Over 400 Per cent!

Rakesh Deshmukh
Heavy Buying Stock Under Rs 25: Debt-Free Microcap Company Bags Order Worth USD 1,01,680; Stock Gains Over 400 Per cent!

The company’s shares have delivered multibagger returns of over 340 per cent to its shareholders in just 2 years.

This micro-cap company is a leading provider of Ayurvedic, herbal, and cosmetic healthcare and personal care products under the brand "Ayuveer," announced that it has received an export order for a new toothpaste variant valued at USD 101,680 (approximately Rs 84 lakhs) from a major institutional supplier in the USA. Following the successful manufacturing and export of oral care products, the company has secured this new order from the top supplier, covering all toothpaste variants marketed by the client in the USA. The order is set to be executed within 3 months.

On Tuesday, the shares of Veer Healthcare Ltd closed at around Rs 23.88 per share. The company’s current market capitalization stands at Rs 47.76 crore. Additionally, the shares have delivered a multibagger return of over 340 per cent in the past 2 years.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

As per the Quarterly Results, in Q4 FY24, Veer Healthcare Ltd recorded a revenue of Rs 3.37 crore representing a de-growth of 9.65 per cent YoY from Rs 3.73 crore. The operating profit for Q4 FY24 stood at Rs 0.17 crore along with an operating profit margin of 5.04 per cent. The net loss for Q4 FY24 stood at Rs 0.55 crore compared to a profit of Rs 1.04 crore last year same quarter. Looking at the annual performance, the company generated a revenue of Rs 13.22 crore in FY24. The operating profit for FY24 was Rs 0.61 crore with a net profit of Rs 0.41 crore compared to a net profit of Rs 1.58 crore in FY23. The company is almost debt-free.

Investors must keep this micro-cap company on their radar.

Disclaimer: The article is for informational purposes only and not investment advice.

Rate this article:
4.0

DSIJ MINDSHARE

Mkt Commentary20-Dec, 2024

Swing Trading22-Dec, 2024

IPO Analysis20-Dec, 2024

Mindshare20-Dec, 2024

IPO Analysis20-Dec, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR